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Acinetobacter Bacteremia in Hong Kong: Prospective Study and Review
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From the Department of Microbiology. The University of Hong Kong.
Hong Kong
The epidcmiological characteristics of 18 patients with acinetobacter bacteremia were analyzed.
Patients {mean age. 55.5 years) developed bacteremia after an average of 14.1 days of hospitalization.
Fifteen of 16 patients survived bacteremia caused by Acinetobacter Ixiumannii. Cultures of blood
from tbe remaining two patients yielded Adnetobacter Iwoffii. Most patients (787<-) resided in the
general ward, while four patients (22%) were under intensive care. Genotyping by arbitrarily primed
polymcrase chain reaction analysis and the temporal sequence of isolation were more useful than
phenotyping by antimicrobial susceptibility in the determination of the source of bacteremia. and
the intravascular catheter was the leading infection source (39'3'r of cases). The possibility of an
association of glucose with the pathogenesis of acinetobacter infection was raised.
In previous studies [1 - 4 ] . the clinical presentation of acinet-
obacter bloodstream infection ranged from mild catheter-re-
lated bacteremia to sepsis (secondary to respiratory tract infec-
tion) requiring intensive care. The incidence of bacteremia
secondary to catheter infection may be underestimated in these
retrospective studies, as catheter tips may not have been cul-
tured routinely. Because we previously demonstrated that Aci-
neiohacier species are endemic at our center in Kong Kong
[5]. we conducted a prospective study to elucidate the epidemi-
ological and clinical characteristics of patients with bacteremia.
In addition, genotyping of isolates by arbitrarily primed PCR
(AP-FCR) analysis was etnployed to determine the source of
bacteremia.
See editorial re.sponse by Seifert on pages 31 - 2 .
Patients and Methods
Patieni seleciUm and evaluation. The prospective study
was carried out at the 1.350-bed Queen Mary Hospital in Hong
Kong over a 5-month period (May to October 1995); patients
whose first pair of blood cultures yielded an Acinetobacter
species were included in the study. Demographic details, body
temperature, and WBC count at the time of positive blood
culture; health and underlying disease history; invasive or diag-
nostic procedures; duration of medication before the onset of
bacteremia; presence of prosthetic devices; total parenteral nu-
trition and use of 5% (w/v) iv glucose at the time of positive
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blood culture; and outcome were recorded. Clinical specimetis
from suspected sources of bacteremia (CNS. respiratory or
urinary tract, and/or wound) were obtained for culture. When
the source of bacteremia was not clinically evident, the site
of insertion of intravascular catheters was examined. Central
catheters were removed for culture when inflammation and pus
were observed at the insertion site, and peripheral catheters
were removed for culture irrespective of the local clinical pre-
sentation. Antimicrobial therapy was initiated after clinical as-
sessment.
Definition.s. Clinically significant bacteremia was defined
as fever (temperature, >38.5°C) and/or leukocytosis ( > l l X
!(}'' WBCs/L) for at least 8 hours. Bacteremia was hospital-
acquired if blood for positive culturc(s) was obtained from a
patient hospitalized for >48 hours. Polymicrobial bacteremia
occurred when more than one organism was isolated from
blood culture(s). Criteria for a favorable outcome included res-
olution of fever and subsequent negative blood cultures. Death
was attributed to bacteremia if the patient died while receiving
therapy within 72 hours of the first positive blood culture.
The source of bacteremia was determined clinically and/or
microbiologically by isolation of an identical Acinetohacter
strain (i.e.. one exhibiting complete genetic rclatedness as de-
termined by AP-PCR analysis) from a distant site before or
during the bacteremic episode. The intravascular catheter Wiis
designated as the primary portal of entry if the same organism
was isolated from the blood and the catheter tip and not from
any other body sites (modification of criteria of Raad and Bo-
dey [6]) and there were > I 5 cfu in culture. No attempts to
recover Acinetobacter strains from stool specimens were made.
The source of bacteremia was unknown when clinical and
microbiological evidence was lacking.
Culture, identification, and susceptibility testing ofAcineto-
hacler strains. Ten milliliters of blood was inoculated into
two bottles for aerobic and anaerobic incubation in BACTEC
NR 660 (Becton Dickinson, Cockeysville, MD). When results
were flagged positive, the contents were cultured on solid me-
dia. The method for scmiquantitative culture of catheter lips
of Maki et al. [7] was used. All other clinical specimens were
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Table 1. Characteristics of 18 patients \\illi clinically significant acinetobacter bacteremia at Queen Mary Hospital in Hong Kong from May
to October 1995.
i'alicnt
no
I
2
3
4
5
6
7
S
y
10
11
12
i3
14
15
16
17
IS
Sex/age (y).
type of patient
F/73. surgical
M/50, surgical
M/54. surgical
M/65, surgical
M/56. surgical
M/62. surgical
F/21. medical
F/60, TCU
M/66. surgical
M.'SO. ICU
M,'i!6, surgical
M/25. inedicLtl
F/35, medical
M/40, medical
F/36. ICU
F/60, ICU
M/73. medical
F/57. medical
Underlying condition(sV
nulritional supplement
(duration in d)
Liver CA/D5 (10)
Liver CA/D5(1)
Esophagus CA, alcoholic
cirrhosis. DM
Stomach C/VTPN (0.5)
Pancreas CA. DM/TPN
(7)
Pancreas CA/D5 (0.5)
Lung CA, chemotherapy
Burkitl's lymphoma.
vcniilatory support/
TPN 10.5}
Pancreatitis, ischemic
heart disease, DM
Acute cliolangitis, liver
ubscess'D5 (27)
Inicsiinal obsinitiion.
liver cirrh(isis/D5 (4j
AML, chemotherapy/D5
(0.5)
AML. chemDtherapy/D5
(7}
After BMT. sicroid
therapy
Meningioma, steroid
therapy, ventilatory
support/D? (7)
CVA. sleroid iherapy.
ventilaiory support.
DM
Ischemic heart disease.
veniilatory support
Myasthcnia gravis.
steroid iherapy.
vcniilatory stipport/iv
iK'parin (6)
Inieniil (d)
between
admission and
onset of
bactcremia/type
of bacteremia
10/iiionomicrobial
2/nionomicrobial
11/monomicrobial
9/mononiierobiai
36/monomicrobial
14/mononiicrobial
0/nionomicrobial
2/polymicrobiai
13/monomicrohial
27/monomicrobial
4/monomicrobial
O,'mon()microbial
7/monomicrobial
59/monomicrobial
10/polyinicrobial
9/monomicrobial
29/nionomicrobial
12/monomicrobial
Uiher culture-
positive specimen
iv catheter
No further specimens
obtained
None
iv catheter
iv catheter
iv calhetcr
None
None
None
Sacral sore
Central venous
catheter
CiitTof Ilickman
catheter
None
None
lEndotracheal aspirate
Tracheostomy
aspirate
Tracheostomy
aspirate
iv calheter.
iracheostomy
aspirate
Antibiotic
therapy at the
time itf blood
sample
No
No
Yes
Yes
Yes
No
No
No
No
No
Yes
No
Yes
No
Yes
No
Yes
No
Antibiotic therapy
Ainoxicitlin/clavutanale and
gentamiein
Aztreonam
Amoxic il 1 in/cia vu 1 anate
imipcncni
Nelilmicin
("elbperazone
Amnxicillin/clavulanate
Imipenem and amikacin
Imipenem
Imipenem
Imipenem
Ceftazidime and amikacin
Ccllazidimc
Imipenem
Imipenem
TriniL'lhoprim-
sullanicthoxazole
Imipenem
CeHazidinie
NOTE. AML = acute myelogenous leukemia; BMT = bone marrow transplantation; CA - carcinoma; CVA - eerebrovascular accident; DM = diabetes
mellitus: D5 = 5% glucose; ICU = intensive care unit: TPN = total parenteral nuiriiiitn.
processed and ciUtured accordingly. .Acinelohacier organisms
were identified according to their abi]ily to oxidize glucose in
lUigh and Leifson's medium [8]. The genospecies of each
blood isolate was determined through PCR analysis of the
conserved spacer region between !6S rRNA and 23S rRNA
[9]. Susceptibility of Acinelnhacier species to antimicrobial
agents was determined by the disk diffusion method [10].
AP-PCR analysis. The genetic rclatedness between the first
Acinctohacier strains isolated from btood and other body site
specimens from each patient was determined by AP-PCR anal-
ysis with use of the primer (GTG). (Molecular Medicine Unit,
Rayne Institute. London) [5] us follows: 2 cycles at 9AX' for
1 tninute, 45''C for 2 minutes, attd 7 2 T for 1 minute; followed
by 25 eyeies at 94°C for I minute. 5 5 T for 0.75 minute, and
72°C for 1 minute; and a terminal extension at ITC for 6
minutes.
Results
Study population. Eighteen patients (11 males and seven
females) had clinieally significant acinetobacter bacteremia
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Table 2. Comparisoti of anlibiograms and AP-PCR profiles for Acinetohacwr strains isolated from
blood and other site specimens from 18 patients with bacteremia at Queen Mary Hospital in Hong Kong
from May to October 1995.
Patient
no.
i
2
3
4
5
6
7
8
9
10
U
12
13
14
15
16
17
18
Antibiogram* {date [d/mo]
Blood
SRSSSSSS (24/5)
RSSSSSSS (24/9)
SRSSSSSS (14/8)
SRRSSSSS (29/5)
SRSRSRRS (2/7)
SRSSSSSS (31/10)
SRSSSSSS (12/8)
SRSSSSSS (5/8)
RRRRSSRR (17/7)
RRRRSRRR (18/10)
SRSRRSSS (19/10)
SRSSSSSR (5/7)
RRSSSSRS(15/8)
RRRSSSSS (23/9)
RRSSSSSS (13/9)
SRSSSSSS (18/7)
SRSSSSSS (20/9)
SRSRSSRS(12/9)
of first isolation) for Acinetohacter strain from
indicated specimen
Olher body site(s)'
Inlravascular catheter. SRSSSSSS (26/5)
None
None
Intravasculat eatheter, SRRSSSSS (1/6)
Inlravascular catheter, SRSRRRRS (1/7)
Intravascular catheter, SRSSSSSS (3/11)
None
None
None
Sacral sore. RRRRSRRR (22/10)
Central venous catheter. SRSRRSSS (2!''1O)
Cuff of Hickman catheter, RRRRSSRS (24/7)
None
None
Endotracheal aspirate, SRSSSSSS (21/9)
Tracheostomy aspirate. SRSSSSSS (14/7)
Tracheostomy aspirate. SRSSSRRS (18/9)
intravascular catheter. SRSRSSRS (16/9);
tracheostomy aspirate, SRSSSSSS (25/9)
Comparative AP-
PCR profile
Identical
ND
ND
Identical
Identical
Identical
ND
ND
ND
Identical
Identical
Identical
ND
ND
Different
Identical
Different
Identical; identical
NOTE. AP-PCR = arbitrarily primed PCR; ND = not determined; R = resistant; S = susceptible,
* Included amoxicillin/clavulanate. cefuroxime, ceftazidime. gentamicin. netilmicin. amikacin. trimethoprim-sulfa-
methoxazole, Lind ofloxacin in that order. Sttaitis exhibiting Intermediate susceptibility were regarded as being resistant.
Differences in susceptibility when compared with that for the blood isolate are shown in bold type,
' Other body site(s) specified before antibiogram(s).
daring the 5-tnonth study period (table 1). One-third of the
patients were 60 years of age or older {mean age ± SD, 55.5
± 18.2 years; range. 21-86 years). Fourteen patients (78%)
resided in general wards (where two intubated patients were
cared for by the intermediate care unit), and four were in the
intensive care utiit (ICU). The mean interval between hospital
admission and the onset of bacteremia was 14.1 days (range. 0 -
59 days). Two patients (nos. 7 and 12) who became bacteremic
during the first day of admission had been hospitalized in the
preceding 2 weeks, and the possibility of them acquiring acinet-
obacter infection during the previous hospitalization could not
be excluded. All patients had fever and/or leukocytosis. Two
patients (11%) had polybacteremia with concomitant organisms
(Enterobacter cloacae, patient 8; Pseudomonas aentginosa,
patient 15).
All patients had underlying diseases, including malignancy
(10 patients), diabetes mellitus (4), conditions requiring steroid
therapy (4). intraabdominal infections (3), and/or ischemic
heart disease (2). Al! patients had intravascular catheters; five
were intubated. and four had urinary tract catheters. Eleven
patients were receiving iv glucose (mean duration, 7,1 days;
range, 0,5-27 days) or total parenterai nutrition (mean dura-
tion, 2.7 days; range,. 0.5-7 days) before the onset of bacter-
emia. Eleven patients did not receive antibiotic therapy when
the first blood sample was obtained for culture. Following the
institution of appropriate antibiotic treatment, all patients ex-
cept one (patient 2) survived.
Microhiulogical characlcrislics. Acinefobacter baumannii
was isolated from 16 patients, and Acinefobacter Iwoffii was
recovered from two (patients 7 and 14). All isolates were resis-
tant to atiipicillin and cephalothin and were susceptible to imi-
penem (these antimicrobial agents were omitted in the antibio-
gram). The genotypic (AP-PCR) and phenotypic (antibiogratn)
patterns of isolates frotn the bloodstream and from other sites
are shown in table 2. Patients 1. 4, 6. 10. 11. 16, and 18 had
blood and catheter, wound, or tracheostomy aspirate i.solates
with identical genotypic and phenotypic pattems, while patients
5 and 12 had isolates with identical genotypes but distinct
phenotypes (figure 1), However, fhe blood and respiratory iso-
lates from patients 15 and 17 had dilYerent genotypie and phe-
notypic pattems. Hence, the sources of bacteremia that were
identified for the 18 patients were the intravascular catheter (7
patients), wound (1), respiratory tract (I), and unknown (9).
) • •
Discussion
The characteristics of acinetobacter bacteremia, especially
those cases caused by ^, baumannii (the tnost prevalent Acinet-
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1,078
S73
Figure I. Representalivc arbitrarily primed PCR profiles for .Icf-
Hi-u>hacier strains isolated from blood and olhcr body site specimens
from patients with baftcremia at Queen Mary Hospital in Hong Kong.
Upper panel: lane MW. //(/clll-digested (/)X174 DNA moleeular size
marker: lanes I and 2. cndotrachcal aspirate isolates from patient 15;
lanes .V 5, tracheostomy aspirate isolates from patient 17: lane 6,
blood isolate from patient 17; lanes 7 -9 , tracheostomy aspirate, cathe-
ter, and blood isolates Irom palieni 18, respectively: lane 10, positive
control .•\cinctohavlcr haunninnii (American Type Culttire Collection
[ATCC] I%O6I, Lower paticl; lane MW, the same DNA molecular
size marker as in the tipper pane!; lane 1, negative control: lanes
2 and 3, tracheostomy aspirate and blood isolates from patient 16,
respectively; lanes 4 and 5, Hickman catheter euft and blood isolates
from patient 12, respectively; lane 6, wound isolate from patient 10;
lanes 7 and H. blood isolates from patient 10; lanes 9 and 10. blood
and endotracheal aspirate isolates from patient 15, respectively.
obaiter isolate from blood), have been reported recently. In
contrast to attributable mortality rates of 19%-34% [1. 2, 4],
there was only one death in our study. Fifteen patients (94%)
survived baeteremic episodes caused by/J, huuimnmii. Smego
[II] also reported a recovery rate of 88% {18 patients). The
difference in mortality rates may be attributed to the different
study populations.
In the previously reported literature,, 4 0 % - 9 1 % of those
patients who developed bactcretiiia were in the ICU [I - 4 , 11],
and they were ot^en infected by multidrug-resistant isolates
[I - 4 ] , The severity of underlying illnesses in the ICU patients
and the itiappropriatc use of antibiotic therapy for patients
infected with multidrug-resistant isolates were independent risk
factors associated with mortality [I. 4], Both characteristics
were absent in our study population: most patients were not
critically ill (only 22% were in the ICU), atid most A. hattman-
nii isolates from blood cultures were susceptible to a number
of antibiotics (table 2), probably associated with the finding
that 61% of the patients had tio previous antibiotic exposure
(table I). The finding of fewer cases of A. hawmmnii bacter-
emia in ICU patients is eonsistent with the results of a previous
5-year study conducted in this liospital (5J, where the propor-
tion of glucose-oxidizing Acinetobacter isolates from baeter-
emic patients in the IC U and general wards was 1:6. In addition,
the major source of.-(. hauimmnii bacteretnia in our patients
was the intravascular catheter, instead of the lower respiratory
tract as reported by other investigators [I. 2. 4, II]. Better
prognoses were reported for patients with A, haunumnii bacter-
emia originating from intravascular eatheterization [1],
The portal of entry of Acinelohactcr strains was established
by recovery of an isolate with genotypic pattern (as demon-
strated by the AP-PCR profile) identical to that of the blood
isolale from a different site. We found i,solates with identical
genotypes that had different susceptibilities to one to four anti-
microbial agents (table 2). Scerpella et al, [12] also repotied
Acinciohactcr strains with cttmplcte genetic relatedness for
which different antibiograms were found. Apart from the geno-
typic relationship, the temporal sequetice of positive cuitures
of blood and other body site specimens was useful in establish-
ing the source of baeteremia (e.g.. in the case of patient 18).
The intravascular catheter atid the lower respiratory tract are
two major portals of etitry for A. haiiiminnii: the intravascular
catheter was the leading infection source in this and other
studies [4. 13. 14], and the respiratory tract was the leading
infection source in other investigations [1 -3 , II], As the ve-
nous access served as the major source of bacteremia in our
study (seven patients), there may be common carriage of the
nonfennenter in patients and/or staff in this hospital; ftirther
stitdy is required for continuation of this hypothesis. Seifert et
al. [4] reported that 57% of all Acinetobacter isolates from
blood were A. hautmmnii and that the leading source of bacter-
emia was the indwelling catheter; tlieir .study included 79 pa-
tients (of whom 79% were In the ICU) in two large and 10
small hospitals during 19W 1991, However, when Seifert and
co-workers [15] sur\eyed the skin surface (forehead, ear, nose,
throat, axilla, hand, groin, perineum, and toe web) of 40 cardiol-
ogy patients in general wards at one of the large lu>spitals
during 1993-1994. A. baumiiimii was found rarely (0.5% of
cases). We note that both studies were carried out during differ-
ent periods and involved dilTerent patient populations; the
length of hospital stay for those patients from whom surveil-
lance swabs were obtained was not stated, and the insertion
site or proximal sutface of foreign bodies was not swabbed.
There may be attributable differences among the genospecies
in their adherenee to foreign bodies and their virulence leading
to disease manifestations.
The source of bacteremia could tiot be established in nine
patients (50%). Other researchers [1 -3 ] reported that the portal
of entry of Aciiiclobacicr strains was not known for 17%-
43% of baeteremic patients. No further clinical specimens were
obtained from a patient who died (patient 2). Intravascular
catheters from patients without clinical foci of bacteremia (pa-
tients 3. 7, 9. 13, and 14) either were cultured after the institu-
tion of antimicrobial therapy (two eases) or were removed
without being cultured (three cases). Since oropharyngeal
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and/or rectal carriage of muitidnig-resistant A. haumaimii is
common in ICU patients [16]. the digestive tract may serve as
a source (e.g.. patient 8 had E. cloacae isolated concurrently
with A. baumannii in the blood culture).
Glucose-oxidizing Acinetobacter strains cause browning of
blood agar incorporated with glucose [9]. The proportion of
diabetic patients with acinetobacter bacteremia in Hong Kong
{19%-22%; this study and [2]) was significant compared with
that (4%-6%) in Vancouver, British Columbia, Canada, and
Cologne. Germany [3. 4] {P < .005. x~ test). Ng et ai. [2]
showed that diabetes mellitus may be a risk factor associated
with mortality in patients with acinetobacter bacteremia, and
Lye et al. [17] suggested that diabetes mellitus could be a
predisposing factor for the development of acinetobacter perito-
nitis in patients undergoing continuous ambulatory peritoneal
dialysis. Whether this association reflects a difference among
the patient populations studied or that diabetes mellitus may
be a risk factor for acinetobacter infections in regions of ende-
micity requires further evaluation.
I
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